Clinical comparison of cefaclor twice daily versus amoxicillin- clavulanate or erythromycin three times daily in the treatment of patients with streptococcal pharyngitis

Clinical Therapeutics

Volumn 20, Issue 1, 1998, Pages 72-79

  Esposito, Silvano ^a,c   De Ritis, Giorgio ^b   D'Errico, Gioacchino ^a   Noviello, Silvana ^a   Ianniello, Filomena ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Ospedale Gesu e Maria   (Italy)

Author keywords

Cefaclor; Children.; Pharyngotonsillitis; Streptococcus pyogenes

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFACLOR; ERYTHROMYCIN; PENICILLIN G; TETRACYCLINE;

ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; RASH; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; THROAT CULTURE; VOMITING;

EID: 0031930439     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(98)80035-0     Document Type: Article

References (28)

1. Hoekelman RA, Starfield B, McCormick M, et al. A profile of pediatric practice in the United States. Am J Dis Child. 1983; 137:1057-1060.
2. Putto A. Febrile exudative tonsillitis: Viral or streptococcal. Pediatrics. 1987;10: 6-12.
3. Brook I. Role of beta-lactamase producing bacteria in the failure of penicillin to eradicate group A streptococci. Pediatr Infect Dis J. 1985;4:491-495.
4. Roos K, Grahn E, Holm SE. Evaluation of beta-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis. Scand J Infect Dis. 1986;18:313-319.
5. Stillerman M. Comparison of oral cephalosporins with penicillin therapy for group A streptococcal pharyngitis. Pediatr Infect Dis J. 1986;5:649-654.
6. Bass JW. Antibiotic management of group A streptococcal pharyngo-tonsillitis. Pediatr Infect Dis J. 1991;10(Suppl 10): s43-s49.
7. Pichichero ME, Margolis PA. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: A meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J. 1991; 10:275-281.
8. National Committee for Control Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. 5th ed. Villanova, PA. NCCLS, 1995.
9. Walsh BT, Bookheim WW, Johnson RC, et al. Recognition of streptococcal pharyngitis in adults. Arch Intern Med. 1975; 135:1493-1497.
10. Breese BB. A simple score card for the tentative diagnosis of streptococcal pharyngitis. Am J Dis Child. 1977;131: 514-517.
11. Centor RM, Meier FA, Dalton HP. Throat culture and rapid test for rapid diagnosis of group A streptococcal pharyngitis. Ann Intern Med. 1986;105:892-899.
12. Kumaroff AL, Pass TM, Aronson MD, et al. The prediction of streptococcal pharyngitis in adults. J Intern Med. 1986;1:1-7.
13. Poses RM, Cebul RD, Collins M, Fager SS. The accuracy of experienced physicians' probability estimates for patients with sore throats. JAMA. 1985;254: 925-929.
14. Moffet HL, Siegel AC, Doyle HK. Non-streptococcal pharyngitis. J Pediatr. 1968; 73:51-60.
15. Pechere JC. Cost-benefit of throat swab in pharyngitis. Med Hygiene. 1996;54:1901-1905.
16. Gastanaduy AS, Howe BB, Kaplan AL, et al. Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis. Lancet. 1980;i:498-501.
17. Howie VM, Ploussard JH. Treatment of group A streptococcal pharyngitis in children. Am J Dis Child. 1971;121:477-180.
18. Pichichero ME, Disney FA, Aronovitz GH, et al. Randomized, single-blind evaluation of cefadroxil and phenoxymethyl penicillin in the treatment of streptococcal pharyngitis. Antimicrob Agents Chemother. 1987; 31:903-906.
19. Feldman S, Bisno AL, Lott L, et al. Efficacy of benzathin penicillin G in group A streptococcal pharyngitis: Reevaluation. J Pediatr. 1987;110:783-787.
20. Kim KS, Kaplan EL. Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. J Pediatr. 1985;107:681-684.
21. Smith TD, Huskins WC, Kaplan EL. Efficacy of beta-lactamase resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis. J Pediair. 1987;110:777-782.
22. Dajani AS, Bisno AL, Chung KJ, et al. Prevention of rheumatic fever. A statement for health professionals by the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, The American Heart Association. Circulation. 1986;78:1082-1086.
23. American Academy of Pediatrics. Group A streptococcal infections. In: Peter E, ed. Report of the Committee on Infectious Diseases. 22nd ed. Elk Grove Village, Ill: American Academy of Pediatrics; 1991: 438-447.
24. Ginsburg CM, McCracken GH, Crow SD, et al. Erythromycin therapy for group A streptococcal pharyngitis. Am J Dis Child. 1984;138:536-539.
25. Milatovic D. Evaluation of cefadroxil, penicillin and erythromycin in the treatment of streptococcal pharyngo-tonsillitis. Pediatr Infect Dis J. 1991;10(Suppl): S61-S63.
26. Camporese A, Tizianel G, Santalena G. Osservatorio epidemiologico sulle resistenze di Streptococcus pyogenes a macrolidi e lincosamidi. Infezioni Med. 1996;2:74-78.
27. Zanacca C, Boschi G, Menozzi MC, et al. Impiego del cefaclor nella faringite streptococcica. Presented at Convegno Nazionale di Antibioticoterapia in età Pediatrica; November 15-16, 1990; Milan, Italy.
28. Dillon HC, Disney FA, McLinn SE, et al. A multiclinic study for the evaluation of cefaclor TID and BID dosage regimens in the treatment of bacterial pharyngitis. Protocol 83. Data on file, Eli Lilly, Indianapolis, Indiana.